Cargando…
The Human Positive Cofactor 4 is a Promising Chemotherapeutic Target in Lung Adenocarcinoma
Reduced sensitivity to chemotherapeutic drugs is almost inevitable in lung adenocarcinoma patients. Thus, understanding the relevant mechanisms is urgent. Positive cofactor 4 (PC4) was at first revealed to be a coactivator of basal transcription. Previous research has shown that PC4 participates in...
Autores principales: | Sun, Tianyu, Zhang, Jingge, Fan, Xiaoqing, Long, Tan, Tao, Shaolin, Kang, Poming, Tan, Qunyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664520/ https://www.ncbi.nlm.nih.gov/pubmed/34899911 http://dx.doi.org/10.1155/2021/9958483 |
Ejemplares similares
-
Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report
por: Wu, Licheng, et al.
Publicado: (2020) -
Comparison of Sleeve Lobectomy for Lung Cancer Using Mini-Thoracotomy and an Optimized Robot-Assisted Technique
por: Shaolin, Tao, et al.
Publicado: (2021) -
Surgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study
por: Deng, Bo, et al.
Publicado: (2017) -
CCR7 promote lymph node metastasis via regulating VEGF-C/D-R3 pathway in lung adenocarcinoma
por: Yu, Jie, et al.
Publicado: (2017) -
NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis
por: Zhang, Zuwang, et al.
Publicado: (2023)